Artificial intelligence (AI) is – if you ask any of Silicon Valley’s top CEOs – the biggest opportunity in their company’s history. Few will tell you that it’s also their biggest threat. “For those ...

With all the attention on the short field topped by Kentucky Derby and Belmont Stakes winner Sovereignty, Saturday’s Grade 1, $1 million Travers has left bettors with a sour taste in their mouth. Many ...

Google has launched Flight Deals, an artificial intelligence-powered feature inside Google Flights designed to help travelers spot the lowest airfare with minimal effort. Currently in beta and ...

As property owners across Montana receive their appraisal notices from the Department of Revenue, many are shocked to find values that are far from reality. It’s clear that Montana property values ...

For decades, Access Engineering PLC has been a foundational pillar of Sri Lanka’s development, its name synonymous with the nation’s roads, bridges, and landmark buildings. Yet, beneath this ...

Massachusetts has one of the best health care systems in the country — with low infant mortality rates, high vaccination rates and the least amount of premature deaths from avoidable causes — and is a ...

For Reuters Pharma Europe 2025, pharmaphorum is providing coverage courtesy NAVLIN Daily, a pricing and market access insights report from EVERSANA (pharmaphorum's parent company). You can see the ...

We're in the thick of the 2025 NFL preseason, which means fantasy managers are getting a good look at some potential late-round values in game situations. While the best fantasy options don't tend to ...

College football betting is among the most popular sports to bet on in the United States. From late August through November, there are more than 50 games available to bet on each week during the ...

The next decade will look very different from the last. Deglobalisation, demographic shifts, and a revival of industrial policy are reshaping the global economy, and with it the foundations of equity ...

With top-line phase 3 results in sight, Rezolute has stepped up preparations for a planned rare disease launch by appointing Sunil Karnawat as its chief commercial officer. Rezolute recently completed ...